ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Reversine and herbal Xiang-Sha-Liu-Jun-Zi decoction ameliorate thioacetamide-induced hepatic injury by regulating the RelA/NF-κB/caspase signaling pathway

Mai, Zhen-Hao; Huang, Yu; Huang, Di; Huang, Zi-Sheng; He, Zhi-Xiang; Li, Pei-Lin; Zhang, Shuai; Weng, Jie-Feng; Gu, Wei-Li*广州医学院; 1
Open Life Sciences2020DOI: 10.1515/biol-2020-0059
3被引12阅读
引用收藏
分享

摘要

This study investigated the anti-fibrotic effects of reversine and Chinese medicine Xiang-Sha-Liu-Jun-Zi decoction (XSLJZD) on thioacetamide (TAA)-induced hepatic injury. Sprague-Dawley rats were intraperitoneally administered with TAA, then injected with reversine intraperitoneally, and/or orally provided with XSLJZD. TAA resulted in liver injury with increases in the liver index and levels of serum aspartate aminotransferase (AST) and alanine aminotransferase. Reversine alleviated the liver index and AST level and improved TAA-induced pathological changes but decreased TAA-induced collagen deposition, and alpha-smooth muscle actin and transforming growth factor-beta 1 expression. Reversine also modulated the mRNA levels of inflammatory cytokines, such as RelA, interleukin (IL)-17A, IL-22, IL-1 beta, IL-6, NLR family pyrin domain containing 3, platelet-derived growth factor, and monocyte chemoattractant protein, and suppressed nuclear factor (NF)-kappa B (p65) phosphorylation and caspase 1 activation. Meanwhile, XSLJZD protected TAA-injured liver without increasing fibrosis and enhanced the regulating effect of reversine on RelA, IL-17A, IL-1 beta, and MCP-1 cytokines. In conclusion, reversine ameliorates liver injury and inhibits inflammation reaction by regulating NF-kappa B, and XSLJZD protects the liver through its synergistic effect with reversine on regulating inflammatory cytokines.

学科与关键词

关键词
liver fibrosisliver indexreversineNF-kappa Bcaspase 1interleukinsXiang-Sha-Liu-Jun-Zi decoction
相关
加载中…
  • Tianhuang formula ameliorates liver fibrosis by inhibiting CCL2-CCR2 axis and MAPK/NF-κB signaling pathway
    Lan, Tian; Chen, Bo; Hu, Xianzhe; Cao, Jiafan; Chen, Shiyun; Ding, Xin; Li, Shengwen; Fu, Yanfang; Liu, Huanle; Luo, Duosheng; Rong, Xianglu; Guo, Jiao*Journal of Ethnopharmacology, 2024, 321: 117516.
  • Antifibrotic mechanism of action based on the corresponding on Traditional Chinese Medicine formula-syndrome to explore Yin-Chen-Hao Decoction regulation of Kupffer cell function and MAPK pathways
    Cao Hongyan; Bian Yanqin; Wu Chao; Li Jianyuan; Liu Ping; Sun Mingyu世界中医药, 2015, (2).
  • Reversine attenuates cholestatic ductular reaction in rats
    Huang, Di; Tang, Lijuan; Li, Tianyang; Li, Peilin; Huang, Zisheng; Weng, Jiefeng; Zhang, Shuai; Gu, Weili*; Huang, Yu*FEBS Open Bio, 2023, 13(5): 898-911.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Open Life Sciences
发表日期
2020
卷期
第 15 卷, 第 1 期
页码
696-710
DOI
10.1515/biol-2020-0059
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
4区
成果收录
SCIE
资助标注
Science and Technology Planning Project of Guangdong Province, China [201806020068]; Guangdong Planned Project of Science and Technology [2013B021800057]; Guangdong Medical Science and Research Foundation [A2020624]; Guangzhou Science and Technology Project of TCM and Combined Chinese and Western Medicine [20172A011004]; Guangzhou General Science and Technology Project of Health and Family Planning [20171A011248, 20181A01002]; Science Foundation of Guangzhou First People's Hospital [M2019003]

作者

  • M

    Mai, Zhen-Hao (第一作者)

    1 · guangzhou med univ

  • H

    Huang, Yu

    1

查看全部 9 位作者收起作者
  • H

    Huang, Di

    1

  • H

    Huang, Zi-Sheng

    1 · guangzhou med univ

  • H

    He, Zhi-Xiang

    1

  • L

    Li, Pei-Lin

    1

  • Z

    Zhang, Shuai

    1

  • W

    Weng, Jie-Feng

    1

  • G

    Gu, Wei-Li (通讯)

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417